[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Hemophilia A Drug Sales Market Report 2017

December 2017 | 112 pages | ID: GE76C3CA8EAEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the global Hemophilia A Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Hemophilia A Drug for these regions, from 2012 to 2022 (forecast), covering
  • United States
  • China
  • Europe
  • Japan
  • Southeast Asia
  • India
Global Hemophilia A Drug market competition by top manufacturers/players, with Hemophilia A Drug sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Bayer AG
  • BioMarin Pharmaceutical Inc
  • Bioverativ Inc
  • Catalyst Biosciences Inc
  • Chugai Pharmaceutical Co Ltd
  • CSL Ltd
  • DBV Technologies SA
  • Dimension Therapeutics Inc
  • EpiVax Inc
  • Expression Therapeutics LLC
  • Green Cross Corp
  • Idogen AB
  • Immusoft Corp
  • LFB SA
  • mAbxience SA
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • ATXF-8117
  • BAY-1093884
  • BIVV-001
  • BS-027125
  • Concizumab
  • CSL-689
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Clinic
  • Hospital
  • ASCs
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Hemophilia A Drug Sales Market Report 2017

1 HEMOPHILIA A DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Hemophilia A Drug
1.2 Classification of Hemophilia A Drug by Product Category
  1.2.1 Global Hemophilia A Drug Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 Global Hemophilia A Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 ATXF-8117
  1.2.4 BAY-1093884
  1.2.5 BIVV-001
  1.2.6 BS-027125
  1.2.7 Concizumab
  1.2.8 CSL-689
  1.2.9 Others
1.3 Global Hemophilia A Drug Market by Application/End Users
  1.3.1 Global Hemophilia A Drug Sales (Volume) and Market Share Comparison by Application (2012-2022)
  1.3.2 Clinic
  1.3.3 Hospital
  1.3.4 ASCs
1.4 Global Hemophilia A Drug Market by Region
  1.4.1 Global Hemophilia A Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 United States Hemophilia A Drug Status and Prospect (2012-2022)
  1.4.3 China Hemophilia A Drug Status and Prospect (2012-2022)
  1.4.4 Europe Hemophilia A Drug Status and Prospect (2012-2022)
  1.4.5 Japan Hemophilia A Drug Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Hemophilia A Drug Status and Prospect (2012-2022)
  1.4.7 India Hemophilia A Drug Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Hemophilia A Drug (2012-2022)
  1.5.1 Global Hemophilia A Drug Sales and Growth Rate (2012-2022)
  1.5.2 Global Hemophilia A Drug Revenue and Growth Rate (2012-2022)

2 GLOBAL HEMOPHILIA A DRUG COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Hemophilia A Drug Market Competition by Players/Suppliers
  2.1.1 Global Hemophilia A Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Global Hemophilia A Drug Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Hemophilia A Drug (Volume and Value) by Type
  2.2.1 Global Hemophilia A Drug Sales and Market Share by Type (2012-2017)
  2.2.2 Global Hemophilia A Drug Revenue and Market Share by Type (2012-2017)
2.3 Global Hemophilia A Drug (Volume and Value) by Region
  2.3.1 Global Hemophilia A Drug Sales and Market Share by Region (2012-2017)
  2.3.2 Global Hemophilia A Drug Revenue and Market Share by Region (2012-2017)
2.4 Global Hemophilia A Drug (Volume) by Application

3 UNITED STATES HEMOPHILIA A DRUG (VOLUME, VALUE AND SALES PRICE)

3.1 United States Hemophilia A Drug Sales and Value (2012-2017)
  3.1.1 United States Hemophilia A Drug Sales and Growth Rate (2012-2017)
  3.1.2 United States Hemophilia A Drug Revenue and Growth Rate (2012-2017)
  3.1.3 United States Hemophilia A Drug Sales Price Trend (2012-2017)
3.2 United States Hemophilia A Drug Sales Volume and Market Share by Players
3.3 United States Hemophilia A Drug Sales Volume and Market Share by Type
3.4 United States Hemophilia A Drug Sales Volume and Market Share by Application

4 CHINA HEMOPHILIA A DRUG (VOLUME, VALUE AND SALES PRICE)

4.1 China Hemophilia A Drug Sales and Value (2012-2017)
  4.1.1 China Hemophilia A Drug Sales and Growth Rate (2012-2017)
  4.1.2 China Hemophilia A Drug Revenue and Growth Rate (2012-2017)
  4.1.3 China Hemophilia A Drug Sales Price Trend (2012-2017)
4.2 China Hemophilia A Drug Sales Volume and Market Share by Players
4.3 China Hemophilia A Drug Sales Volume and Market Share by Type
4.4 China Hemophilia A Drug Sales Volume and Market Share by Application

5 EUROPE HEMOPHILIA A DRUG (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Hemophilia A Drug Sales and Value (2012-2017)
  5.1.1 Europe Hemophilia A Drug Sales and Growth Rate (2012-2017)
  5.1.2 Europe Hemophilia A Drug Revenue and Growth Rate (2012-2017)
  5.1.3 Europe Hemophilia A Drug Sales Price Trend (2012-2017)
5.2 Europe Hemophilia A Drug Sales Volume and Market Share by Players
5.3 Europe Hemophilia A Drug Sales Volume and Market Share by Type
5.4 Europe Hemophilia A Drug Sales Volume and Market Share by Application

6 JAPAN HEMOPHILIA A DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Hemophilia A Drug Sales and Value (2012-2017)
  6.1.1 Japan Hemophilia A Drug Sales and Growth Rate (2012-2017)
  6.1.2 Japan Hemophilia A Drug Revenue and Growth Rate (2012-2017)
  6.1.3 Japan Hemophilia A Drug Sales Price Trend (2012-2017)
6.2 Japan Hemophilia A Drug Sales Volume and Market Share by Players
6.3 Japan Hemophilia A Drug Sales Volume and Market Share by Type
6.4 Japan Hemophilia A Drug Sales Volume and Market Share by Application

7 SOUTHEAST ASIA HEMOPHILIA A DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Hemophilia A Drug Sales and Value (2012-2017)
  7.1.1 Southeast Asia Hemophilia A Drug Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia Hemophilia A Drug Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia Hemophilia A Drug Sales Price Trend (2012-2017)
7.2 Southeast Asia Hemophilia A Drug Sales Volume and Market Share by Players
7.3 Southeast Asia Hemophilia A Drug Sales Volume and Market Share by Type
7.4 Southeast Asia Hemophilia A Drug Sales Volume and Market Share by Application

8 INDIA HEMOPHILIA A DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 India Hemophilia A Drug Sales and Value (2012-2017)
  8.1.1 India Hemophilia A Drug Sales and Growth Rate (2012-2017)
  8.1.2 India Hemophilia A Drug Revenue and Growth Rate (2012-2017)
  8.1.3 India Hemophilia A Drug Sales Price Trend (2012-2017)
8.2 India Hemophilia A Drug Sales Volume and Market Share by Players
8.3 India Hemophilia A Drug Sales Volume and Market Share by Type
8.4 India Hemophilia A Drug Sales Volume and Market Share by Application

9 GLOBAL HEMOPHILIA A DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 Bayer AG
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Hemophilia A Drug Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Bayer AG Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 BioMarin Pharmaceutical Inc
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Hemophilia A Drug Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 BioMarin Pharmaceutical Inc Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 Bioverativ Inc
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Hemophilia A Drug Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Bioverativ Inc Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 Catalyst Biosciences Inc
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Hemophilia A Drug Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 Catalyst Biosciences Inc Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 Chugai Pharmaceutical Co Ltd
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Hemophilia A Drug Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 Chugai Pharmaceutical Co Ltd Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview
9.6 CSL Ltd
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Hemophilia A Drug Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 CSL Ltd Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.6.4 Main Business/Business Overview
9.7 DBV Technologies SA
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Hemophilia A Drug Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 DBV Technologies SA Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.7.4 Main Business/Business Overview
9.8 Dimension Therapeutics Inc
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Hemophilia A Drug Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 Dimension Therapeutics Inc Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.8.4 Main Business/Business Overview
9.9 EpiVax Inc
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Hemophilia A Drug Product Category, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 EpiVax Inc Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.9.4 Main Business/Business Overview
9.10 Expression Therapeutics LLC
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Hemophilia A Drug Product Category, Application and Specification
    9.10.2.1 Product A
    9.10.2.2 Product B
  9.10.3 Expression Therapeutics LLC Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  9.10.4 Main Business/Business Overview
9.11 Green Cross Corp
9.12 Idogen AB
9.13 Immusoft Corp
9.14 LFB SA
9.15 mAbxience SA

10 HEMOPHILIA A DRUG MAUFACTURING COST ANALYSIS

10.1 Hemophilia A Drug Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Hemophilia A Drug
10.3 Manufacturing Process Analysis of Hemophilia A Drug

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Hemophilia A Drug Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Hemophilia A Drug Major Manufacturers in 2016
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL HEMOPHILIA A DRUG MARKET FORECAST (2017-2022)

14.1 Global Hemophilia A Drug Sales Volume, Revenue and Price Forecast (2017-2022)
  14.1.1 Global Hemophilia A Drug Sales Volume and Growth Rate Forecast (2017-2022)
  14.1.2 Global Hemophilia A Drug Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global Hemophilia A Drug Price and Trend Forecast (2017-2022)
14.2 Global Hemophilia A Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  14.2.1 Global Hemophilia A Drug Sales Volume and Growth Rate Forecast by Regions (2017-2022)
  14.2.2 Global Hemophilia A Drug Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.3 United States Hemophilia A Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 China Hemophilia A Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Europe Hemophilia A Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 Japan Hemophilia A Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.7 Southeast Asia Hemophilia A Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.8 India Hemophilia A Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Hemophilia A Drug Sales Volume, Revenue and Price Forecast by Type (2017-2022)
  14.3.1 Global Hemophilia A Drug Sales Forecast by Type (2017-2022)
  14.3.2 Global Hemophilia A Drug Revenue Forecast by Type (2017-2022)
  14.3.3 Global Hemophilia A Drug Price Forecast by Type (2017-2022)
14.4 Global Hemophilia A Drug Sales Volume Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Hemophilia A Drug
Figure Global Hemophilia A Drug Sales Volume Comparison (K Pcs) by Type (2012-2022)
Figure Global Hemophilia A Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure ATXF-8117 Product Picture
Figure BAY-1093884 Product Picture
Figure BIVV-001 Product Picture
Figure BS-027125 Product Picture
Figure Concizumab Product Picture
Figure CSL-689 Product Picture
Figure Others Product Picture
Figure Global Hemophilia A Drug Sales Comparison (K Pcs) by Application (2012-2022)
Figure Global Sales Market Share of Hemophilia A Drug by Application in 2016
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure ASCs Examples
Table Key Downstream Customer in ASCs
Figure Global Hemophilia A Drug Market Size (Million USD) by Regions (2012-2022)
Figure United States Hemophilia A Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Hemophilia A Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Hemophilia A Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Hemophilia A Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Hemophilia A Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Hemophilia A Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Hemophilia A Drug Sales Volume (K Pcs) and Growth Rate (2012-2022)
Figure Global Hemophilia A Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Hemophilia A Drug Sales Volume (K Pcs) (2012-2017)
Table Global Hemophilia A Drug Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table Global Hemophilia A Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Hemophilia A Drug Sales Share by Players/Suppliers
Figure 2017 Hemophilia A Drug Sales Share by Players/Suppliers
Figure Global Hemophilia A Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Hemophilia A Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Hemophilia A Drug Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Hemophilia A Drug Revenue Share by Players
Table 2017 Global Hemophilia A Drug Revenue Share by Players
Table Global Hemophilia A Drug Sales (K Pcs) and Market Share by Type (2012-2017)
Table Global Hemophilia A Drug Sales Share (K Pcs) by Type (2012-2017)
Figure Sales Market Share of Hemophilia A Drug by Type (2012-2017)
Figure Global Hemophilia A Drug Sales Growth Rate by Type (2012-2017)
Table Global Hemophilia A Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Hemophilia A Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Hemophilia A Drug by Type (2012-2017)
Figure Global Hemophilia A Drug Revenue Growth Rate by Type (2012-2017)
Table Global Hemophilia A Drug Sales Volume (K Pcs) and Market Share by Region (2012-2017)
Table Global Hemophilia A Drug Sales Share by Region (2012-2017)
Figure Sales Market Share of Hemophilia A Drug by Region (2012-2017)
Figure Global Hemophilia A Drug Sales Growth Rate by Region in 2016
Table Global Hemophilia A Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Hemophilia A Drug Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Hemophilia A Drug by Region (2012-2017)
Figure Global Hemophilia A Drug Revenue Growth Rate by Region in 2016
Table Global Hemophilia A Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Hemophilia A Drug Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Hemophilia A Drug by Region (2012-2017)
Figure Global Hemophilia A Drug Revenue Market Share by Region in 2016
Table Global Hemophilia A Drug Sales Volume (K Pcs) and Market Share by Application (2012-2017)
Table Global Hemophilia A Drug Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Hemophilia A Drug by Application (2012-2017)
Figure Global Hemophilia A Drug Sales Market Share by Application (2012-2017)
Figure United States Hemophilia A Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure United States Hemophilia A Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Hemophilia A Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table United States Hemophilia A Drug Sales Volume (K Pcs) by Players (2012-2017)
Table United States Hemophilia A Drug Sales Volume Market Share by Players (2012-2017)
Figure United States Hemophilia A Drug Sales Volume Market Share by Players in 2016
Table United States Hemophilia A Drug Sales Volume (K Pcs) by Type (2012-2017)
Table United States Hemophilia A Drug Sales Volume Market Share by Type (2012-2017)
Figure United States Hemophilia A Drug Sales Volume Market Share by Type in 2016
Table United States Hemophilia A Drug Sales Volume (K Pcs) by Application (2012-2017)
Table United States Hemophilia A Drug Sales Volume Market Share by Application (2012-2017)
Figure United States Hemophilia A Drug Sales Volume Market Share by Application in 2016
Figure China Hemophilia A Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure China Hemophilia A Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Hemophilia A Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table China Hemophilia A Drug Sales Volume (K Pcs) by Players (2012-2017)
Table China Hemophilia A Drug Sales Volume Market Share by Players (2012-2017)
Figure China Hemophilia A Drug Sales Volume Market Share by Players in 2016
Table China Hemophilia A Drug Sales Volume (K Pcs) by Type (2012-2017)
Table China Hemophilia A Drug Sales Volume Market Share by Type (2012-2017)
Figure China Hemophilia A Drug Sales Volume Market Share by Type in 2016
Table China Hemophilia A Drug Sales Volume (K Pcs) by Application (2012-2017)
Table China Hemophilia A Drug Sales Volume Market Share by Application (2012-2017)
Figure China Hemophilia A Drug Sales Volume Market Share by Application in 2016
Figure Europe Hemophilia A Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Hemophilia A Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Hemophilia A Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Europe Hemophilia A Drug Sales Volume (K Pcs) by Players (2012-2017)
Table Europe Hemophilia A Drug Sales Volume Market Share by Players (2012-2017)
Figure Europe Hemophilia A Drug Sales Volume Market Share by Players in 2016
Table Europe Hemophilia A Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Europe Hemophilia A Drug Sales Volume Market Share by Type (2012-2017)
Figure Europe Hemophilia A Drug Sales Volume Market Share by Type in 2016
Table Europe Hemophilia A Drug Sales Volume (K Pcs) by Application (2012-2017)
Table Europe Hemophilia A Drug Sales Volume Market Share by Application (2012-2017)
Figure Europe Hemophilia A Drug Sales Volume Market Share by Application in 2016
Figure Japan Hemophilia A Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Japan Hemophilia A Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Hemophilia A Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Japan Hemophilia A Drug Sales Volume (K Pcs) by Players (2012-2017)
Table Japan Hemophilia A Drug Sales Volume Market Share by Players (2012-2017)
Figure Japan Hemophilia A Drug Sales Volume Market Share by Players in 2016
Table Japan Hemophilia A Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Japan Hemophilia A Drug Sales Volume Market Share by Type (2012-2017)
Figure Japan Hemophilia A Drug Sales Volume Market Share by Type in 2016
Table Japan Hemophilia A Drug Sales Volume (K Pcs) by Application (2012-2017)
Table Japan Hemophilia A Drug Sales Volume Market Share by Application (2012-2017)
Figure Japan Hemophilia A Drug Sales Volume Market Share by Application in 2016
Figure Southeast Asia Hemophilia A Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Southeast Asia Hemophilia A Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Hemophilia A Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Southeast Asia Hemophilia A Drug Sales Volume (K Pcs) by Players (2012-2017)
Table Southeast Asia Hemophilia A Drug Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Hemophilia A Drug Sales Volume Market Share by Players in 2016
Table Southeast Asia Hemophilia A Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Southeast Asia Hemophilia A Drug Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Hemophilia A Drug Sales Volume Market Share by Type in 2016
Table Southeast Asia Hemophilia A Drug Sales Volume (K Pcs) by Application (2012-2017)
Table Southeast Asia Hemophilia A Drug Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Hemophilia A Drug Sales Volume Market Share by Application in 2016
Figure India Hemophilia A Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure India Hemophilia A Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Hemophilia A Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table India Hemophilia A Drug Sales Volume (K Pcs) by Players (2012-2017)
Table India Hemophilia A Drug Sales Volume Market Share by Players (2012-2017)
Figure India Hemophilia A Drug Sales Volume Market Share by Players in 2016
Table India Hemophilia A Drug Sales Volume (K Pcs) by Type (2012-2017)
Table India Hemophilia A Drug Sales Volume Market Share by Type (2012-2017)
Figure India Hemophilia A Drug Sales Volume Market Share by Type in 2016
Table India Hemophilia A Drug Sales Volume (K Pcs) by Application (2012-2017)
Table India Hemophilia A Drug Sales Volume Market Share by Application (2012-2017)
Figure India Hemophilia A Drug Sales Volume Market Share by Application in 2016
Table Bayer AG Basic Information List
Table Bayer AG Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bayer AG Hemophilia A Drug Sales Growth Rate (2012-2017)
Figure Bayer AG Hemophilia A Drug Sales Global Market Share (2012-2017
Figure Bayer AG Hemophilia A Drug Revenue Global Market Share (2012-2017)
Table BioMarin Pharmaceutical Inc Basic Information List
Table BioMarin Pharmaceutical Inc Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure BioMarin Pharmaceutical Inc Hemophilia A Drug Sales Growth Rate (2012-2017)
Figure BioMarin Pharmaceutical Inc Hemophilia A Drug Sales Global Market Share (2012-2017
Figure BioMarin Pharmaceutical Inc Hemophilia A Drug Revenue Global Market Share (2012-2017)
Table Bioverativ Inc Basic Information List
Table Bioverativ Inc Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bioverativ Inc Hemophilia A Drug Sales Growth Rate (2012-2017)
Figure Bioverativ Inc Hemophilia A Drug Sales Global Market Share (2012-2017
Figure Bioverativ Inc Hemophilia A Drug Revenue Global Market Share (2012-2017)
Table Catalyst Biosciences Inc Basic Information List
Table Catalyst Biosciences Inc Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Catalyst Biosciences Inc Hemophilia A Drug Sales Growth Rate (2012-2017)
Figure Catalyst Biosciences Inc Hemophilia A Drug Sales Global Market Share (2012-2017
Figure Catalyst Biosciences Inc Hemophilia A Drug Revenue Global Market Share (2012-2017)
Table Chugai Pharmaceutical Co Ltd Basic Information List
Table Chugai Pharmaceutical Co Ltd Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Chugai Pharmaceutical Co Ltd Hemophilia A Drug Sales Growth Rate (2012-2017)
Figure Chugai Pharmaceutical Co Ltd Hemophilia A Drug Sales Global Market Share (2012-2017
Figure Chugai Pharmaceutical Co Ltd Hemophilia A Drug Revenue Global Market Share (2012-2017)
Table CSL Ltd Basic Information List
Table CSL Ltd Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure CSL Ltd Hemophilia A Drug Sales Growth Rate (2012-2017)
Figure CSL Ltd Hemophilia A Drug Sales Global Market Share (2012-2017
Figure CSL Ltd Hemophilia A Drug Revenue Global Market Share (2012-2017)
Table DBV Technologies SA Basic Information List
Table DBV Technologies SA Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure DBV Technologies SA Hemophilia A Drug Sales Growth Rate (2012-2017)
Figure DBV Technologies SA Hemophilia A Drug Sales Global Market Share (2012-2017
Figure DBV Technologies SA Hemophilia A Drug Revenue Global Market Share (2012-2017)
Table Dimension Therapeutics Inc Basic Information List
Table Dimension Therapeutics Inc Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Dimension Therapeutics Inc Hemophilia A Drug Sales Growth Rate (2012-2017)
Figure Dimension Therapeutics Inc Hemophilia A Drug Sales Global Market Share (2012-2017
Figure Dimension Therapeutics Inc Hemophilia A Drug Revenue Global Market Share (2012-2017)
Table EpiVax Inc Basic Information List
Table EpiVax Inc Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure EpiVax Inc Hemophilia A Drug Sales Growth Rate (2012-2017)
Figure EpiVax Inc Hemophilia A Drug Sales Global Market Share (2012-2017
Figure EpiVax Inc Hemophilia A Drug Revenue Global Market Share (2012-2017)
Table Expression Therapeutics LLC Basic Information List
Table Expression Therapeutics LLC Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Expression Therapeutics LLC Hemophilia A Drug Sales Growth Rate (2012-2017)
Figure Expression Therapeutics LLC Hemophilia A Drug Sales Global Market Share (2012-2017
Figure Expression Therapeutics LLC Hemophilia A Drug Revenue Global Market Share (2012-2017)
Table Green Cross Corp Basic Information List
Table Idogen AB Basic Information List
Table Immusoft Corp Basic Information List
Table LFB SA Basic Information List
Table mAbxience SA Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hemophilia A Drug
Figure Manufacturing Process Analysis of Hemophilia A Drug
Figure Hemophilia A Drug Industrial Chain Analysis
Table Raw Materials Sources of Hemophilia A Drug Major Players in 2016
Table Major Buyers of Hemophilia A Drug
Table Distributors/Traders List
Figure Global Hemophilia A Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Global Hemophilia A Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Hemophilia A Drug Price (USD/Pcs) and Trend Forecast (2017-2022)
Table Global Hemophilia A Drug Sales Volume (K Pcs) Forecast by Regions (2017-2022)
Figure Global Hemophilia A Drug Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Hemophilia A Drug Sales Volume Market Share Forecast by Regions in 2022
Table Global Hemophilia A Drug Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Hemophilia A Drug Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Hemophilia A Drug Revenue Market Share Forecast by Regions in 2022
Figure United States Hemophilia A Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Hemophilia A Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Hemophilia A Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Hemophilia A Drug Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Hemophilia A Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Europe Hemophilia A Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Hemophilia A Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Hemophilia A Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Hemophilia A Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Hemophilia A Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Hemophilia A Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Hemophilia A Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Hemophilia A Drug Sales (K Pcs) Forecast by Type (2017-2022)
Figure Global Hemophilia A Drug Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Hemophilia A Drug Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Hemophilia A Drug Revenue Market Share Forecast by Type (2017-2022)
Table Global Hemophilia A Drug Price (USD/Pcs) Forecast by Type (2017-2022)
Table Global Hemophilia A Drug Sales (K Pcs) Forecast by Application (2017-2022)
Figure Global Hemophilia A Drug Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories